Diversified Healthcare Trust (DHC) to Release Quarterly Earnings on Monday

Diversified Healthcare Trust (NASDAQ:DHC) is projected to post its Q4 2025 results after the market closes on Monday, February 23rd. Analysts expect the company to announce earnings of $0.12 per share and revenue of $392.8890 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 10:00 AM ET.

Diversified Healthcare Trust Price Performance

DHC opened at $6.55 on Monday. Diversified Healthcare Trust has a 1 year low of $2.00 and a 1 year high of $6.61. The company’s 50 day simple moving average is $5.43 and its 200 day simple moving average is $4.62. The stock has a market capitalization of $1.59 billion, a PE ratio of -4.49 and a beta of 2.43. The company has a debt-to-equity ratio of 1.61, a quick ratio of 16.89 and a current ratio of 16.89.

Diversified Healthcare Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, February 19th. Shareholders of record on Monday, January 26th will be issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, January 26th. Diversified Healthcare Trust’s dividend payout ratio (DPR) is -2.74%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Royal Bank Of Canada upgraded Diversified Healthcare Trust from an “underperform” rating to a “sector perform” rating and upped their price objective for the stock from $3.00 to $5.00 in a report on Thursday, November 13th. Zacks Research downgraded Diversified Healthcare Trust from a “hold” rating to a “strong sell” rating in a research report on Thursday, January 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a report on Wednesday, January 21st. Finally, B. Riley Financial reaffirmed a “buy” rating and issued a $6.50 price objective (up from $5.50) on shares of Diversified Healthcare Trust in a research note on Monday, December 15th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $5.75.

Insider Transactions at Diversified Healthcare Trust

In other news, CEO Christopher J. Bilotto purchased 20,000 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was acquired at an average cost of $4.89 per share, with a total value of $97,800.00. Following the acquisition, the chief executive officer owned 266,285 shares in the company, valued at approximately $1,302,133.65. This trade represents a 8.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 10.06% of the stock is owned by company insiders.

Institutional Investors Weigh In On Diversified Healthcare Trust

A number of institutional investors have recently modified their holdings of DHC. Carronade Capital Management LP increased its stake in Diversified Healthcare Trust by 4.4% during the fourth quarter. Carronade Capital Management LP now owns 4,763,537 shares of the real estate investment trust’s stock valued at $23,103,000 after purchasing an additional 201,789 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its position in shares of Diversified Healthcare Trust by 8.5% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 347,101 shares of the real estate investment trust’s stock valued at $1,681,000 after buying an additional 27,215 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Diversified Healthcare Trust by 13.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 5,108,830 shares of the real estate investment trust’s stock worth $24,778,000 after acquiring an additional 619,750 shares during the period. Martingale Asset Management L P lifted its holdings in Diversified Healthcare Trust by 9.8% in the fourth quarter. Martingale Asset Management L P now owns 182,962 shares of the real estate investment trust’s stock worth $887,000 after acquiring an additional 16,354 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its stake in Diversified Healthcare Trust by 42.1% in the fourth quarter. Wells Fargo & Company MN now owns 261,361 shares of the real estate investment trust’s stock valued at $1,268,000 after acquiring an additional 77,468 shares during the period. Institutional investors and hedge funds own 75.98% of the company’s stock.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.